FDA Guides On Pathway For Competitive Generic Therapies

 
• By Grace Montgomery

Draft guidance on the approval pathway for competitive generic therapies (CGTs) has been published by the FDA in the agency’s latest move to advance generic drug competition.

RoadClouds
The FDA has created a new pathway for CGTs • Source: Shutterstock

More from Generics

More from Products